SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins rebound and consolidation near recent highs have sparked widespread calls for a breakout, with bullish traders anticipating further gains and a possible short squeeze. Others call the move a bear-market bounce and warn that repeated resistance and a loss of support could reverse it.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins rebound and expectations for further crypto strength are driving interest in MSTR as a leveraged Bitcoin proxy. Traders are divided between anticipating a breakout or short squeeze and warning of pullbacks, volatility, and dilution.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeeds sharp, volatile rebound is driving speculation about a short squeeze, with traders pointing to high reported short interest and the companys LITEON partnership on silicon-carbide power solutions for AI data centers. Others remain skeptical, citing weak recent results, negative margins and ongoing cash-burn concerns.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing attention for its weekly distributions, with traders debating payout amounts and dividend eligibility. Views on the funds MSTR- and Bitcoin-linked exposure are split between hopes for a price recovery and concerns about shrinking payouts and NAV erosion.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

UECs fiscal 2026 results have drawn attention: uranium production ramped sharply as the company moved toward multi-mine production, but its quarterly loss missed expectations. Traders are divided between viewing higher output and a debt-free balance sheet as encouraging progress and questioning the selloff, ongoing losses, and ability to turn production into consistent profits.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention after a push to fresh highs, with traders highlighting a breakout and renewed strength in Magnificent Seven stocks. Bulls see mega-cap tech reclaiming market leadership, while others warn that gains remain concentrated and broader market breadth is weak.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMs push toward its recent highs is drawing attention amid reports of early talks with Elon Musks Terafab over a possible Texas chip-manufacturing partnership, alongside broader AI-chip optimism and heavy bullish call-flow chatter. Traders are eyeing a breakout, while some warn of resistance and a potential pullback; the partnership remains speculative.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

UUUUs steep selloff and underperformance versus uranium and rare-earth peers dominate discussion, with traders blaming a weak critical-minerals sector, macro pressure, and short selling rather than pointing to one confirmed catalyst. Sentiment is sharply divided between frustrated holders citing ongoing downside and buyers viewing the stock as oversold, while long-term bulls continue to point to its uranium and mine-to-magnet ambitions.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is in focus amid a sharp gold selloff as rising Treasury yields and expectations for further Fed rate hikes weigh on the non-yielding asset. Traders are split between expecting more downside and treating the pullback as a buying opportunity, citing longer-term concerns about debt, inflation and safe-haven demand.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention as an Ethereum-treasury play, with traders focused on its reported progress toward a 5% ETH holding and speculation about a larger target. The debate centers on whether ETH exposure will create shareholder value or whether possible share dilution and the stocks perceived underperformance versus ETH are offsetting that appeal; bullish traders emphasize long-term crypto upside, while critics question the strategy and valuation.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 83.4% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse

Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here is what investors need to know.read more...

Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. futures rose, but Novo Nordisk fell 4.8% after Cagrisema trial results; Aligos, Telix and other stocks also dropped premarket.read more...

Telix Pharma To Acquire ITM In Deal Worth Up To $2.35 Bln

(RTTNews) - Telix Pharmaceuticals Ltd. (TLX,TLX.AX) announced that it signed an agreement to acquire privately held ITM Isotope Technologies Munich SE in a transaction valued at up to US$2.35 billion, strengthening its position in the global radiopharmaceutical and radioisotope m...

FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug

FDA approves Telix Pharmaceuticals' Pixclara, the first radiopharmaceutical brain cancer imaging drug for glioma PET scans.read more...

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent 

Equity

The FDA’s target date for deciding on Pixclara is September 11.

Does Telix Pharmaceuticals Limited (TLX) Have the Potential to Rally 86.17% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 86.2% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Business

(RTTNews) - Telix Pharmaceuticals Limited (TLX), a radiopharmaceutical company, reported a rise in revenue for the second quarter, helped by the increased revenue from the precision medicine business...

Telix Pharmaceuticals Limited (NASDAQ:TLX) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine research firms that are presently covering the stock...

Telix Pharmaceuticals Webinar Highlights Next-Gen PSMA Therapy, OPTIMAL-PSMA Enrollment Nears End

Telix Pharmaceuticals (NASDAQ:TLX) hosted an educational webinar outlining its next-generation prostate-specific membrane antigen (PSMA) radiopharmaceutical strategy, with management and a clinical...

Telix Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development and commercialization of several clinical-stage oncology assets. The firm operates through the following segments: Therapeutics (Tx), Precision Medicine (Px), and Telix Manufacturing Solutions (TMS). The Tx segment focuses on development of targeted radionuclide therapies for urologic and neurologic oncology, and other solid tumors. The Px segment includes provision of diagnostic imaging solutions to market and expanding into new geographies and indications. The TMS segment comprises of costs to operate the firm's facilities and assets. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East and Africa. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in North Melbourne, Australia.

Telix Pharmaceuticals Ltd. - ADR

Extremely Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$10.55
Prev Close	$10.72
Open	$10.64
Dividend Yield	0.00%
50-Day Moving Average	$11.37
Beta	0.00
Avg. Volume	481,180.72
PE Ratio	106.46

52-Week High	$13.11
52-Week Low	$6.28
Market Capitalization	$3.59B
EPS (Annual)	-$0.0211
Price to Book	7.35
Revenue Per Employee	$679,591.93

Feed

News

Sentiment

Earnings

Fundamentals

Info

TLX Fundamentals